Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?

被引：3
|
作者：
Garassino, Marina Chiara [1 ]
Farina, Gabriella [1 ]
Rossi, Antonio [2 ]
Martelli, Olga [3 ]
Torri, Valter [4 ]
机构：
[1] Fatebenefratelli & Oftalm Hosp, Dept Oncol, Milan, Italy
[2] SG Moscati Hosp, Div Oncol, Avellino, Italy
[3] San Giovanni Hosp, Dept Oncol, Rome, Italy
[4] Mario Negri Inst Pharmacol Res, Dept Oncol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/JCO.2008.16.8195
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2600 / 2600
页数：1
相关论文
共 50 条
  • [1] Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?: Reply
    Lievre, Astrid
    Laurent-Puig, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2601 - 2602
  • [2] KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
    Lievre, Astrid
    Bachet, Jean-Baptiste
    Boige, Valerie
    Cayre, Anne
    Le Corre, Delphine
    Buc, Emmanuel
    Ychou, Marc
    Bouche, Olivier
    Landi, Bruno
    Louvet, Christophe
    Andre, Thierry
    Bibeau, Frederic
    Diebold, Marie-Daniele
    Rougier, Philippe
    Ducreux, Michel
    Tomasic, Gorana
    Emile, Jean-Francois
    Penault-Llorca, Frederique
    Laurent-Puig, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 374 - 379
  • [3] ACTIVATING KRAS MUTATIONS AS AN INDEPENDENT PREDICTOR IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH CETUXIMAB
    Lin, O. S. R.
    ANNALS OF ONCOLOGY, 2010, 21 : I36 - I36
  • [4] Kras mutations in colorectal cancer is a predictive factor of response and survival in patients treated with cetuximab
    Laurent-Puig, P.
    Livre, A.
    Boige, V
    Bachet, J.
    Ychou, M.
    Bouche, O.
    Pezet, D.
    Landi, B.
    Louvet, C.
    Andre, T.
    Ducreux, M.
    Rougier, P.
    Penault-Llroca, F.
    ANNALS OF ONCOLOGY, 2007, 18 : VII81 - VII81
  • [5] Activating KRAS Mutations and Overexpression of Epidermal Growth Factor Receptor as Independent Predictors in Metastatic Colorectal Cancer Patients Treated With Cetuximab
    Yen, Li-Chen
    Uen, Yih-Huei
    Wu, Deng-Chyang
    Lu, Chien-Yu
    Yu, Fang-Jung
    Wu, I-Chen
    Lin, Shiu-Ru
    Wang, Jaw-Yuan
    ANNALS OF SURGERY, 2010, 251 (02) : 254 - 260
  • [6] KRAS mutations as a prognostic factor after metastasectomy in colorectal cancer patients
    Domenech Vinolas, M.
    Santos, C.
    Perez, J.
    Varela, M.
    Martinez Villacampa, M.
    Teule, A.
    Ruffinelli Rodriguez, J. C.
    Mulet Margalef, N.
    Soler, G.
    Ortega, A.
    Bergamino, M. S.
    SanJuan, X.
    Torras, J.
    Ramos, E.
    Salazar, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] KRAS gene mutations - prognostic factor in colorectal cancer?
    Dobre, Maria
    Dinu, Daniela Elena
    Panaitescu, Eugenia
    Birla, Rodica Daniela
    Iosif, Cristina-Ileana
    Boeriu, Marius
    Constantinoiu, Silviu
    Ivan, Roxana Nicoleta
    Ardeleanu, Carmen Maria
    Costache, Marieta
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2015, 56 (02): : 671 - 678
  • [8] Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies
    Qiu, Li-Xin
    Mao, Chen
    Zhang, Jian
    Zhu, Xiao-Dong
    Liao, Ru-Yan
    Xue, Kai
    Li, Jin
    Chen, Qing
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (15) : 2781 - 2787
  • [9] The prognostic value of KRAS mutations in patients with colorectal cancer
    Inoue, Yasuhiro
    Saigusa, Susumu
    Iwata, Takashi
    Okugawa, Yoshinaga
    Toiyama, Yuji
    Tanaka, Koji
    Uchida, Keiichi
    Mohri, Yasuhiko
    Kusunoki, Masato
    ONCOLOGY REPORTS, 2012, 28 (05) : 1579 - 1584
  • [10] Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
    Koulouridi, Asimina
    Karagianni, Michaela
    Messaritakis, Ippokratis
    Sfakianaki, Maria
    Voutsina, Alexandra
    Trypaki, Maria
    Bachlitzanaki, Maria
    Koustas, Evangelos
    Karamouzis, Michalis, V
    Ntavatzikos, Anastasios
    Koumarianou, Anna
    Androulakis, Nikolaos
    Mavroudis, Dimitrios
    Tzardi, Maria
    Souglakos, John
    CANCERS, 2022, 14 (14)
12345